ID: ALA5084927

Max Phase: Preclinical

Molecular Formula: C5H6IN3O5

Molecular Weight: 315.02

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(CI)N1CC([N+](=O)[O-])([N+](=O)[O-])C1

Standard InChI:  InChI=1S/C5H6IN3O5/c6-1-4(10)7-2-5(3-7,8(11)12)9(13)14/h1-3H2

Standard InChI Key:  ZJAWKXCGDDGRNF-UHFFFAOYSA-N

Associated Targets(non-human)

SCC-7 114 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 315.02Molecular Weight (Monoisotopic): 314.9352AlogP: -0.49#Rotatable Bonds: 3
Polar Surface Area: 106.59Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 0.47CX LogD: 0.47
Aromatic Rings: 0Heavy Atoms: 14QED Weighted: 0.23Np Likeness Score: -0.50

References

1. Oronsky B, Guo X, Wang X, Cabrales P, Sher D, Cannizzo L, Wardle B, Abrouk N, Lybeck M, Caroen S, Oronsky A, Reid TR..  (2021)  Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development.,  64  (11.0): [PMID:34043360] [10.1021/acs.jmedchem.1c00599]

Source